Pfizer and Allergan Reportedly Close to a Deal as Treasury Reviews Inversions

-Pfizer-set-to-make-highe-011Various media outlets are reporting that even as the U.S. Treasury may be preparing to adopt a stricter stance toward corporate tax inversions, Pfizer is continuing to pursue a potential acquisition of Allergan. If the massive merger gets done, it could be worth approximately $150 billion, according to Reuters.

Buying Allergan would give Pfizer a chance to redomicile in Ireland and avoid the U.S. higher corporate tax rate. In response to an analyst’s question about inversions, Pfizer CEO Ian Read, Pfizer CEO and chairman said during a late-October earnings call that, “To be successful in the future, we need to have a competitive tax rate,” according to a Seeking Alpha transcript.

Allergan issued a press release in late October confirming the company “has been approached by Pfizer Inc. and is in preliminary friendly discussions regarding a potential business combination transaction. . . ”  On an earnings call earlier this month, Brent Saunders, Allergan CEO and president, declined to confirm whether “business combination” discussions were about Pfizer’s interest in potentially acquiring Allergan.

READ THE REST HERE

About Peter Coffaro 1439 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.


*